Replies to post #78001 on Ayala Pharmaceuticals Inc (ADXS)

[mortmann]

1st, being short is a hedge, risk mitigation for me. Not to be confused with averaging down, eg., increasing exposure.

2nd, absent a deal, my guess is dilution occurring as that is the easiest way and its incentivised contractually for Mgmt to do it, and likely the only option available. Its going to take time to draw the value out of HOT. A raise, while screwing existing investors, provides for runway to HOT data. Do I think it happens in 2018? It makes sense, absent a deal.